OMEZENT

EUIPO EUIPO 2013 Registration expired

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OMEZENT was filed as Word mark on 01/24/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/23/2013. The current status of the mark is "Registration expired".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 011516192
Application date January 24, 2013
Publication date May 16, 2013
Entry date August 23, 2013
Expiration date January 24, 2023

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis, prevention and/or treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants; pharmaceutical preparations

Trademark history

Date Document number Area Entry
November 24, 2023 Extension, Trade mark expired
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11011516192